Industry News

Aperion Biologics appoints new members to its board of directors

Aperion Biologics Inc. recently announced France Dixon Helfer and Mike Ward were appointed to the company’s board of directors.

Helfer currently serves as president and chief executive officer (CEO) of Halo Healthcare Inc. and was most recently the founder and CEO of Pegasus Biologics. Ward has more than 20 years of life sciences-dedicated investment banking, venture capital and private equity experience.  He currently serves on the boards of Nanosphere Inc. and CytoPherx Inc.

“France and Mike bring a wealth of experience, from private equity, venture capital, entrepreneurship, product development and business development,” Daniel Lee, CEO of the Aperion Biologics, stated in a company press release. “Their extraordinary industry experience will be a huge asset to the company as we move forward with our Z-Lig device, the first non-human biologic device for ACL reconstruction of the knee.”

 

Aperion Biologics Inc. recently announced France Dixon Helfer and Mike Ward were appointed to the company’s board of directors.

Helfer currently serves as president and chief executive officer (CEO) of Halo Healthcare Inc. and was most recently the founder and CEO of Pegasus Biologics. Ward has more than 20 years of life sciences-dedicated investment banking, venture capital and private equity experience.  He currently serves on the boards of Nanosphere Inc. and CytoPherx Inc.

“France and Mike bring a wealth of experience, from private equity, venture capital, entrepreneurship, product development and business development,” Daniel Lee, CEO of the Aperion Biologics, stated in a company press release. “Their extraordinary industry experience will be a huge asset to the company as we move forward with our Z-Lig device, the first non-human biologic device for ACL reconstruction of the knee.”